Paradoxical relationships of interleukin-6 and tumor necrosis factor-alpha with methamphetamine use and body mass index
Abstract
Background:: Methamphetamine (MA) use and obesity are linked to inflammation and related comorbidities, yet their combined effects are poorly understood. We evaluated associations between MA use, body mass index (BMI), and systemic inflammation.
Methods:: We analyzed data and specimens from 140 men in a longitudinal cohort with biannual visits, over 4 visits (560 specimens). We created a three-level MA use variable by combining urine drug tests with past 6-month self-reported MA use: no use, intermittent use, and frequent use. Serum samples were analyzed for interleukin (IL)−6 and tumor necrosis factor (TNF)-α. Mixed-effects linear models assessed associations between MA use and cytokine levels. Interaction terms evaluated the joint effect of MA and BMI on inflammation.
Results:: Median age is 35. Across visits, MA use is frequent (19.3% of visits), intermittent (19.1%), and none (61.6%). BMI is lowest among those with frequent MA use ( p < 0.001). MA use and BMI are positively associated with IL-6, but their interaction is negatively associated with both IL-6 and TNF-α.
Conclusions:: MA use and BMI appear to jointly influence systemic inflammation. Frequent MA use combined with higher BMI is associated with lower IL-6 and TNF-α, potentially reflecting reduced energy expenditure and increased appetite contributing to higher BMI.
Related
- Patients with cyclops syndrome exhibit elevated synovial fluid interleukin‐6 (IL‐6) and tumor necrosis factor alpha (TNF‐α) levels and disorganized collagen remodelling within the lesion: A histological and molecular study
- Preventive Immunomodulatory Effects of Doxycycline and Hyperbaric Oxygen Therapy on Serum Tumor Necrosis Factor-α and Interleukin-6 Levels in a Rat Model of Malaria.
- Comparative efficacy of aerobic training, resistance training, combined training, and multicomponent exercise on interleukin-6, C-reactive protein, and tumor necrosis factor-α levels in older adults (≥60 years): a systematic review and network meta-analysis.
- Systematic Review and Meta-Analysis on Central and/or Peripheral Nervous System Demyelination in Patients Treated With Tumor Necrosis Factor Alpha (TNF-α) Inhibitors
- Abnormally low expression of tumor necrosis factor stimulated gene 6 (TSG-6) in obese type 2 diabetic mice contributes to altered inflammation and delayed cutaneous wound healing
BibTeX
@article{blair2026paradoxical,
title = {{Paradoxical relationships of interleukin-6 and tumor necrosis factor-alpha with methamphetamine use and body mass index}},
author = {Cheríe S. Blair and Jennifer A. Fulcher and Paola Ruiz and Pamina M. Gorbach and Steven Shoptaw and Jesse L. Clark},
journal = {Communications Medicine},
year = {2026},
month = oct,
doi = {10.1038/s43856-026-01929-4},
url = {https://www.nature.com/articles/s43856-026-01929-4},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Paradoxical relationships of interleukin-6 and tumor necrosis factor-alpha with methamphetamine use and body mass index
AU - Cheríe S. Blair
AU - Jennifer A. Fulcher
AU - Paola Ruiz
AU - Pamina M. Gorbach
AU - Steven Shoptaw
AU - Jesse L. Clark
PY - 2026
DA - 2026/10/07
JO - Communications Medicine
DO - 10.1038/s43856-026-01929-4
UR - https://www.nature.com/articles/s43856-026-01929-4
AB - Background:: Methamphetamine (MA) use and obesity are linked to inflammation and related comorbidities, yet their combined effects are poorly understood. We evaluated associations between MA use, body mass index (BMI), and systemic inflammation. Methods:: We analyzed data and specimens from 140 men in a longitudinal cohort with biannual visits, over 4 visits (560 specimens). We created a three-level MA use variable by combining urine drug tests with past 6-month self-reported MA use: no use, intermittent use, and frequent use. Serum samples were analyzed for interleukin (IL)−6 and tumor necrosis factor (TNF)-α. Mixed-effects linear models assessed associations between MA use and cytokine levels. Interaction terms evaluated the joint effect of MA and BMI on inflammation. Results:: Median age is 35. Across visits, MA use is frequent (19.3% of visits), intermittent (19.1%), and none (61.6%). BMI is lowest among those with frequent MA use ( p < 0.001). MA use and BMI are positively associated with IL-6, but their interaction is negatively associated with both IL-6 and TNF-α. Conclusions:: MA use and BMI appear to jointly influence systemic inflammation. Frequent MA use combined with higher BMI is associated with lower IL-6 and TNF-α, potentially reflecting reduced energy expenditure and increased appetite contributing to higher BMI.
SN - 2730-664X
ER -